In 2023, the GLP-1 industry was worth $37.4B
Goal: moderate weight loss (10 to 15% of body weight) If your target is 10 to 15% body weight reduction, you may not need to escalate beyond 4 to 8 mg
Those who are pregnant or breastfeeding may also want to avoid GLP-1 agonists, as the safety of these medications during pregnancy has not been well-established
Compounded tirzepatide comes in various concentrations
NEITHER MTA NOR ANYONE ASSOCIATED WITH MTA SHALL BE LIABLE IN ANY EVENT FOR ANY DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL, INCIDENTAL OR PUNITIVE DAMAGES THAT RESULT FROM OR RELATE IN ANY MANNER WHATSOEVER TO (1) YOUR USE OF THIS SITE, OR RELIANCE ON THE CONTENT, OR (2) ERRORS, INACCURACIES, OMISSIONS, DEFECTS, UNTIMELINESS, SECURITY BREACHES, OR ANY OTHER FAILURE TO PERFORM BY MTA OR ITS CONTENT PROVIDERS
These medicines can be expensive, insurance coverage is often limited, and many patients pay out of pocket